Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient

by Andrea Boutros, Andrea Boutros, Chiara Schiavi, Federica Cecchi, Francesco Spagnolo, Antonio Guadagno, Enrica Teresa Tanda, Francesca Giusti, Giuseppe Murdaca, Paola Queirolo
Published 2020-11-01

Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma

by Andrea Boutros, Andrea Boutros, Federica Cecchi, Enrica Teresa Tanda, Enrica Teresa Tanda, Elena Croce, Elena Croce, Riccardo Gili, Riccardo Gili, Luca Arecco, Luca Arecco, Francesco Spagnolo, Paola Queirolo
Published 2021-08-01

Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review

by Francesco Spagnolo, Andrea Boutros, Federica Cecchi, Elena Croce, Enrica Teresa Tanda, Paola Queirolo
Published 2021-04-01

Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?

by Enrica Teresa Tanda, Enrica Teresa Tanda, Agostina Lagodin d’Amato, Agostina Lagodin d’Amato, Giovanni Rossi, Giovanni Rossi, Elena Croce, Elena Croce, Andrea Boutros, Andrea Boutros, Federica Cecchi, Francesco Spagnolo, Paola Queirolo
Published 2021-09-01

How to Protect Ovarian Function before and during Chemotherapy?

by Luca Arecco, Tommaso Ruelle, Valentino Martelli, Andrea Boutros, Maria Maddalena Latocca, Stefano Spinaci, Camilla Marrocco, Claudia Massarotti, Matteo Lambertini
Published 2021-09-01

Current State of Target Treatment in BRAF Mutated Melanoma

by Enrica Teresa Tanda, Irene Vanni, Irene Vanni, Andrea Boutros, Virginia Andreotti, Virginia Andreotti, William Bruno, William Bruno, Paola Ghiorzo, Paola Ghiorzo, Francesco Spagnolo
Published 2020-07-01

Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications

by Irene Vanni, Irene Vanni, Enrica Teresa Tanda, Bruna Dalmasso, Bruna Dalmasso, Lorenza Pastorino, Lorenza Pastorino, Virginia Andreotti, Virginia Andreotti, William Bruno, William Bruno, Andrea Boutros, Francesco Spagnolo, Paola Ghiorzo, Paola Ghiorzo
Published 2020-07-01